First Clinical Study Validates Fluorescence Imaging for Orthopaedic Surgery Applications

Pioneering Research in Orthopaedic Surgery

In a landmark study, researchers at MolecuLight and The Royal Orthopaedic Hospital NHS Foundation Trust (ROH) have unveiled compelling findings that underscore the potential of fluorescence imaging technology in orthopaedic surgery. This study marks the first clinical evidence supporting the use of real-time fluorescence imaging during revision knee arthroplasties aimed at treating periprosthetic joint infections.

Published in BMJ Open, this feasibility study highlights the challenges of managing periprosthetic joint infections, a serious complication that can arise after joint replacement surgeries. Successful intervention relies heavily on the complete removal of infected tissue to minimize the risk of ongoing or recurrent infections. Identifying all regions of bacterial contamination during surgery is often a daunting task for surgeons.

The investigation involved ten patients at ROH, where standard surgical debridement procedures were enhanced using the MolecuLight fluorescence imaging device. With this advanced technology, surgeons were able to visualize areas of residual bacterial contamination that might not be apparent during conventional debridement. Specifically, following the initial surgery, tissues exhibiting bacterial fluorescence were biopsied, allowing for microbiological analyses that reaffirmed the presence of bacterial pathogens linked to the infection.

Professor Jonathon Stevenson, a leading consultant orthopaedic surgeon at the Royal Orthopaedic Hospital and senior author of the study, expressed optimism regarding the use of MolecuLight. He noted, “This feasibility study indicates that the MolecuLight device may assist surgeons in elevating their radical debridement efforts during revision knee surgeries for prosthetic joint infections. This crucial step is vital for reducing the morbidity associated with recurrent infections.”

Furthermore, Mr. James Archer, a Specialty Registrar in Trauma and Orthopaedics and the first author of the study, echoed the excitement surrounding these groundbreaking results. “This feasibility study provides the inaugural documentation suggesting that MolecuLight can support real-time surgical decision-making during complex revision procedures,” he stated, looking forward to conducting more extensive studies to explore its capabilities in greater detail.

Anil Amlani, CEO of MolecuLight, also praised the research conducted at ROH, interpreting it as a notable milestone for the use of fluorescence imaging in surgical fields beyond traditional chronic wound treatment. He emphasized the significance of this publication, stating, “Their study lays the groundwork for future clinical investigations, spotlighting the potential of real-time fluorescence imaging in enhancing surgical outcomes.”

This innovative study opens new avenues for the application of MolecuLight in perioperative surgical settings on a global scale. By delivering immediate visual data regarding overlooked bacterial loads, this technology holds the promise of augmenting intraoperative decision-making, ultimately leading to better patient outcomes. Going forward, additional research will be essential to further correlate fluorescence imaging findings with positive surgical results.

About The Institutions

The Royal Orthopaedic Hospital NHS Foundation Trust stands as one of Europe's preeminent specialist orthopaedic centers, devoted to providing exceptional planned orthopaedic surgery nationally and internationally. Known for its commitment to research and innovation, the Trust boasts diverse clinical trials and studies aimed at exploring new treatment methodologies and medical devices.

MolecuLight, a trailblazing medical imaging firm, manufactures advanced imaging devices capable of real-time detection of bacterial presence in wounds. The Class II FDA-cleared platforms contribute significantly to comprehensive wound care management, an essential factor reinforced by extensive peer-reviewed literature.

In closing, this study signifies a noteworthy advancement in the realm of orthopaedic medicine, paving the way for future innovations that can potentially transform surgical practices worldwide.